L-tryptophan Induced Eosinophilia-Myalgia Syndrome

Belongia, E.A. , Hedberg, C.W. , Gleich, G.J. , White. K.E. , Mayeno, A.N. , Loegering, D.A. , Dunnette, S.L. , Pirie, P.L. , Macdonald, K.L. , and Osterholm, M.T. (1990). An Investigation of the Cause of the Eosinophilia-Myalgia Syndrome Associated with Tryptophan Use. N. Eng. J. Med. 323: 357-365.

Centers for Disease Control (1981). Follow-up on toxic pneumonia — Spain. MMWR 30: 436-8.

Centers for Disease Control (1989a). Eosinophilia-Myalgia Syndrome — New Mexico. MMWR, Centers for Disease Control, 38 (45): 765-67.

Centers for Disease Control (1989b). Eosinophilia-Myalgia Syndrome and L-tryptophan-containing-products — New Mexico, Minneosata, Oregon, and New York 1989. MMWR 38 (46): 785-88.

Centers for Disease Controls (1989c). Update: Eosinophil-Myalgia Syndrome associataed with ingestion of L-tryptophan — United States. MMWR, 38 (48): 842-3.

FDA Acting Director Douglas Archer warns Dietary Supplement L-tryptophan, Linked to sometimes Fatal Blood Disorder ... (28 March 1990 ), The New York Times C12:5.

Fischbach, F.T. (1988). A Manual of Laboratory Diagnostic Tests. Philadelphia, T.B. Lippincott Co., 29.

Food and Drug Admimstration (1990). Expanded Recall for L-tryptophan. FDA Drug Bulletin 20 (1): 2-3.

Hertzman, P.A. (1990). Treatment of the Eosinopilia-Myalgia Syndrome (letter). N. Eng. J. Med. 323 (6): 417.

Kilbourne, E.M. , Rigau-Perez, J.G. , Heath, C.W. Jr. , Zack, M.M. , Falk, H. , Martin-Marcos, M. , and De Carlos, A. (1983). Clinical epidemiology of Toxic-Oil Syndrome. N. Eng. J. Med. 309: 1408-14.

Martinez-Tello, F.J. , Navus-Palacios J.J. , Ricoy, J.R. (1982). Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain — Virchows Arch (A) 397: 261-85.

Putnam, S. (8 August 1990). Syndrome that cripples, kills touches Batesville. The Panolian 108 (34): 6a.

Silver, R.M. , Heyes, M.P. , Maize, J.C. , Quearry, B. , Vionnet-Fuasset, M. , Sternberg, E. M (1990). Scleroderma, faciitis and eosinophilia associated with the ingestion of tryptophan. N. Eng. J. Med. 322: 874-81.

Sternberg, E.M. , Van Woert, M.H. , Young, S.N. , Magnussen, Ib. , Baker, H. , Gauthier, S. and Osterland, C.K. (1980). Development of a scleroderma-like illness during therapy with L-5-Hydroxytryptophan and carbidopa. N. Eng. J. Med., 303: 782-87.

Swyers, James P. (1990). Tracking Tryptophan-Induced Illness Research Resources Reporter, U.S. Department of Health and Human Services, National Institute of Health, 14 (8): 1-4.

Tabuenca, J.M. , (1981). Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 2: 567-8.

Toxic Epidemic Syndrome Study Group (1982). Toxic epidemic syndrome, Spain — 1981. Lancet 2: 697-702.

U.S. Public Health Services, EMS Hotline ( 1990). Taken from recording 26-8-90 telephone no. (1-800-EMS 2829) obtained from Letter to Editor. N. Eng. J. Med. 323 (6): 417.